A product for treating conditions and/or symptoms associated with women healthis described, which product comprisesat least one cannabinoid in a specific amount, a primary terpene in a specificamount, at least 5% by weight of a non-cannabinoid, non-terpene,carrier, optionally at least three secondary terpenes, and optionally at leastone phytoestrogen； wherein said non-cannabinoid,non-terpene carrier comprises cellulose and the terpenes to cannabinoidsweight/weight ratio in said product is about 0.1 to about 1ØAlso described is the above product wherein said non-cannabinoid, non-terpenecarrier comprises less than 5% by weight cellulose andthe terpenes to cannabinoids weight/weight ratio in said compositions is about0.05 to about 1.0, forming a terpene-enriched product withan enhanced therapeutic effect in treating conditions and/ or symptomsassociated with perimenopause, menopause, female urogenitalor reproductive system infections and/or disorders, menstrual cycle, hormonaldeficiency and/or hormonal imbalance, compared withthat of a product comprising the same cannabinoids amounts and one half theamount of said primary terpene.
